Table 5 Internal fixation versus prosthetic implant for C+ versus C−

Tot number of patients (%)

24/53 (45%)

243/424 (57%)

0.107

29/53 (55%)

181/424 (43%)

0.107

CI₉₅

0.33–0.59

0.53–0.62

1.62 (0.91–2.88)

0.41–0.67

0.38–0.47

0.62 (0.35–1.09)

Age (mean ± SD)

84.3 ± 1.3

81.7 ± 0.7

0.274

82.5 ± 1.4

80.5 ± 0.7

0.282

CI₉₅

83.75–84.85

81.61–81.79

2.6 (2.28–2.92)

81.97–83.03

80.40–80.60

2.00 (1.67–2.33)

ASA (mean ± SD)

2.7 ± 0.1

2.6 ± 0.1

0.301

2.6 ± 0

2.6 ± 0.1

0.951

Median (IQR_25–75)

3 (2–4)

3 (2–4)

0.431^a

3 (2–4)

3 (2–4)

0.752^a

30-day mortality

8/24 (33%)

13/243 (5%)

0.0002

4/29 (14%)

7/181 (4%)

0.048

CI₉₅

0.18–0.53

0.03–0.09

0.11 (0.04–0.31)

0.05–0.31

0.02–0.08

0.25 (0.07–0.92)